Macrosyn 100 mg/ml injektionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

macrosyn 100 mg/ml injektionsvæske, opløsning

bimeda animal health limited - tulathromycin - injektionsvæske, opløsning - 100 mg/ml

Tullavis 100 mg/ml injektionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

tullavis 100 mg/ml injektionsvæske, opløsning

livisto int´l s.l. - tulathromycin - injektionsvæske, opløsning - 100 mg/ml

Tullavis 25 mg/ml injektionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

tullavis 25 mg/ml injektionsvæske, opløsning

livisto int´l s.l. - tulathromycin - injektionsvæske, opløsning - 25 mg/ml

Canigen L4 Den Europæiske Union - dansk - EMA (European Medicines Agency)

canigen l4

intervet international b.v. - inaktiverede leptospira-stammer: l. interrogans serogruppe canicola serovar portland-vere (stamme ca-12-000); l. interrogans serogruppe serovar icterohaemorrhagiae copenhageni (stamme ic-02-001); l. interrogans serogruppe australis serovar bratislava (stamme, som-05-073); l. kirschneri serogruppe grippotyphosa serovar dadas (stamme gr-01-005) - immunologicals for canidae, inaktiveret, bakterielle vacciner (herunder mycoplasma, toxoid og chlamydia) - hunde - til aktiv immunisering af hunde mod: l. interrogans serogruppe canicola serovar canicola at reducere infektion og urinudskillelse;l. interrogans serogruppe serovar icterohaemorrhagiae copenhageni at reducere infektion og urinudskillelse;l. interrogans serogruppe australis serovar bratislava for at reducere infektion;l. kirschneri serogruppe grippotyphosa serovar bananal / lianguang for at reducere infektion og urinudskillelse.

Coxevac Den Europæiske Union - dansk - EMA (European Medicines Agency)

coxevac

ceva santé animale - inaktiveret coxiella burnetii vaccine, stamme nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.